OSE Immunotherapeutics (LTS:0RAD) Valuation Rank


LTS:0RAD OSE Immunotherapeutics SA LTS:0RAD
51 GF Score
Price €3.63
GF Value €1.44
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is OSE Immunotherapeutics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

OSE Immunotherapeutics Valuation Rank Related Terms

LTS:0RAD
51GF Score
OSE Immunotherapeutics SA LTS:0RAD
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OSE Immunotherapeutics (LTS:0RAD) Overvalued in 2026?

Based on GuruFocus' analysis, OSE Immunotherapeutics stock appears to be overvalued. The current stock price of €3.63 is trading 152.1% above its estimated GF Value™ of €1.44. GuruFocus considers OSE Immunotherapeutics to be Significantly Overvalued.

Key valuation signals for LTS:0RAD:

  • Valuation Rank:
  • GF Value™: €1.44 vs. price of €3.63 (152.1% above fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OSE Immunotherapeutics Business Description

Address 22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
51GF Score

Get the complete analysis for LTS:0RAD

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.63
Price
€1.44
GF Value